First-Line Treatment for Schizophrenia

Initial Treatment Approach

The initial choice of antipsychotic medication should be made collaboratively with the patient based on side-effect and efficacy profiles, with antipsychotic treatment offered to individuals who have experienced a week or more of psychotic symptoms with associated distress or functional impairment 1, 2, 3
Antipsychotic treatment should be initiated early, especially when symptoms cause severe distress or if there are safety concerns to self or others 4, 5
The first antipsychotic medication should be given at a therapeutic dose for at least 4 weeks, assuming good adherence 1
Treatment decisions should incorporate patient preferences regarding side effects, efficacy, and route of administration 5, 6
If a patient is unable to engage in discussion, input from friends and family should be sought, with the patient engaged in decision making as soon as appropriate 2

First-generation and second-generation antipsychotics are not distinct categories from either a pharmacological or clinical perspective, and this classification should not be used to guide medication choice 1, 3

First-line treatment should select an antipsychotic based on patient preference regarding side effects 5, efficacy profile 2, dosing convenience 1, and availability of long-acting formulation 1, 2, 3
If inadequate response after 4 weeks, switch to an alternative antipsychotic with a different pharmacodynamic profile 1
For patients whose first-line treatment was a D2 partial agonist, consider amisulpride, risperidone, paliperidone, or olanzapine (with either samidorphan combination or concurrent metformin) 1, 3
If inadequate response to second antipsychotic after 4 weeks, reassess diagnosis and potential contributing factors (organic illness, substance use) 2
If schizophrenia diagnosis is confirmed, consider a trial of clozapine 1, 3, 4
Metformin should be offered concomitantly with clozapine to attenuate potential weight gain 1

Treatment effectiveness should be assessed early, with a proactive approach when commencing, switching, or augmenting treatment 2, 4
Document target symptoms, treatment response, and suspected side effects 7, 9
Monitor for known side effects specific to the chosen medication (e.g., extrapyramidal symptoms, weight gain, metabolic changes) 7, 9
Long-term monitoring to reassess dosage needs based on the stage of illness, with higher doses potentially required during acute phases and lower doses during residual phases 9